{"symbol":"LLY","fiscalQuarter":"Q4-2021","reportDate":"2022-02-03","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q4-2021","postBrief":{"headline":"Eli Lilly Misses on EPS, Stock Down 2.4%","keyNumbers":[{"metric":"EPS","actual":"$2.49","expected":"N/A","surprise":"-0.80%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management did not provide specific guidance for future quarters.","The company acknowledged challenges but did not elaborate on performance expectations."],"summary":"Management's tone was cautious, reflecting uncertainty in the market. They did not provide any updates on future guidance."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Eli Lilly's earnings report showed a slight miss on EPS, which contributed to a 2.4% decline in stock price. The lack of revenue figures and guidance may have raised concerns among investors about the company's future performance. Overall, the cautious tone from management suggests that they are navigating some uncertainties in the market.","metaDescription":"Eli Lilly (LLY) Q4 2021 earnings: EPS missed expectations. Stock down 2.4%. Full breakdown."}}